 |
|
NSAIDs Associated With Increased Risk of Congestive Heart Failure in Elderly Patients Taking Diuretics
Eibert R. Heerdink, PhD;
Hubert G. Leufkens, PhD;
Ron M. C. Herings, PhD;
Jan P. Ottervanger, MD;
Bruno H. C. Stricker, MD;
Albert Bakker, PhD
Arch Intern Med. 1998;158:1108-1112.
Background Both diuretics and nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used, in particular among the elderly. The use of NSAIDs may decrease the efficacy of diuretics and induce congestive heart failure (CHF) in patients treated with diuretics.
Objective To investigate the risk of CHF associated with combined use of diuretics and NSAIDs in patients older than 55 years.
Methods We conducted a study in a base cohort of 10519 recipients of diuretics and NSAIDs identified in the PHARMO database during the period from 1986 through 1992. The incidence density of hospitalizations for CHF during exposure to both diuretics and NSAIDs (index) was compared with that during exposure to diuretics only (reference).
Results We found an overall increased risk of hospitalization for CHF during periods of concomitant use of diuretics and NSAIDs compared with use of diuretics only (crude relative risk, 2.2; 95% confidence interval, 1.7-2.9). After adjusting for cofactors including age, sex, history of hospitalization, and drug use, a 2-fold increased risk remained (relative risk, 1.8; 95% confidence interval, 1.4-2.4).
Conclusion Use of NSAIDs in elderly patients taking diuretics is associated with a 2-fold increased risk of hospitalization for CHF, especially in those with existing serious CHF.
From the Department of Pharmacoepidemiology and Pharmacotherapy, University of Utrecht, Utrecht, the Netherlands (Drs Heerdink, Leufkens, Herings, and Bakker); Department of Epidemiology and Biostatistics, Erasmus University, Rotterdam, the Netherlands (Drs Ottervanger and Stricker); and Department of Cardiology, Hospital "De Weezenlanden," Zwolle, the Netherlands (Dr Ottervanger).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Prevention of Heart Failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group
Schocken et al.
Circulation 2008;117:2544-2565.
ABSTRACT
| FULL TEXT
Review: Adverse cardiovascular effects of NSAIDs: driven by blood pressure, or edema?
Aneja and Farkouh
Therapeutic Advances in Cardiovascular Disease 2008;2:53-66.
ABSTRACT
Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population
Huerta et al.
Heart 2006;92:1610-1615.
ABSTRACT
| FULL TEXT
NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland
Helin-Salmivaara et al.
Eur Heart J 2006;27:1657-1663.
ABSTRACT
| FULL TEXT
Understanding the NSAID related risk of vascular events.
Vonkeman et al.
BMJ 2006;332:895-898.
FULL TEXT
Mortality and Morbidity Remain High Despite Captopril and/or Valsartan Therapy in Elderly Patients With Left Ventricular Systolic Dysfunction, Heart Failure, or Both After Acute Myocardial Infarction: Results From the Valsartan in Acute Myocardial Infarction Trial (VALIANT)
White et al.
Circulation 2005;112:3391-3399.
ABSTRACT
| FULL TEXT
Aspirin Use in Chronic Heart Failure: What Should We Recommend to the Practitioner?
Massie
J Am Coll Cardiol 2005;46:963-966.
ABSTRACT
| FULL TEXT
Palliative Care for Patients With Heart Failure
Pantilat and Steimle
JAMA 2004;291:2476-2482.
ABSTRACT
| FULL TEXT
Keeping Your Patient With Heart Failure Safe: A Review of Potentially Dangerous Medications
Amabile and Spencer
Arch Intern Med 2004;164:709-720.
FULL TEXT
Prescribing Indicators for Evaluating Drug Use in Nursing Homes
van Dijk et al.
The Annals of Pharmacotherapy 2003;37:1136-1141.
ABSTRACT
| FULL TEXT
Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery
Ott et al.
J. Thorac. Cardiovasc. Surg. 2003;125:1481-1492.
ABSTRACT
| FULL TEXT
N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease
Gerrits et al.
Eur Respir J 2003;21:795-798.
ABSTRACT
| FULL TEXT
Loop diuretics: from the Na-K-2Cl transporter to clinical use
Shankar and Brater
Am. J. Physiol. Renal Physiol. 2003;284:F11-F21.
ABSTRACT
| FULL TEXT
Association of Nonsteroidal Anti-inflammatory Drugs With First Occurrence of Heart Failure and With Relapsing Heart Failure: The Rotterdam Study
Feenstra et al.
Arch Intern Med 2002;162:265-270.
ABSTRACT
| FULL TEXT
Failing ageing hearts
Petrie et al.
Eur Heart J 2001;22:1978-1990.
Use of Sympathomimetic Drugs Leads to Increased Risk of Hospitalization for Arrhythmias in Patients With Congestive Heart Failure
Bouvy et al.
Arch Intern Med 2000;160:2477-2480.
ABSTRACT
| FULL TEXT
Consumption of NSAIDs and the Development of Congestive Heart Failure in Elderly Patients: An Underrecognized Public Health Problem
Page and Henry
Arch Intern Med 2000;160:777-784.
ABSTRACT
| FULL TEXT
|
